These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30253685)

  • 1. A clinical review and introduction of the diagnostic algorithm for thalidomide embryopathy (DATE).
    Mansour S; Baple E; Hall CM
    J Hand Surg Eur Vol; 2019 Jan; 44(1):96-108. PubMed ID: 30253685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The teratogenic effects of thalidomide on limbs.
    Vargesson N
    J Hand Surg Eur Vol; 2019 Jan; 44(1):88-95. PubMed ID: 30335598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teratogen update: clinical aspects of thalidomide embryopathy--a continuing preoccupation.
    Newman CG
    Teratology; 1985 Aug; 32(1):133-44. PubMed ID: 4035587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratogen-induced limb defects.
    Holmes LB
    Am J Med Genet; 2002 Oct; 112(3):297-303. PubMed ID: 12357474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The thalidomide experience: review of its effects 50 years later].
    Martínez-Frías ML
    Med Clin (Barc); 2012 Jun; 139(1):25-32. PubMed ID: 22177324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide embryopathy: Follow-up of cases born between 1959 and 2010.
    Kowalski TW; Sanseverino MT; Schuler-Faccini L; Vianna FS
    Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):794-803. PubMed ID: 26043318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thalidomide and unilateral limb defects: the Italian chapter of a neverending story].
    Terracini B
    Epidemiol Prev; 2021; 45(4):302-309. PubMed ID: 34549573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thalidomide epidemics: 50 years after].
    Sípek A; Sípek A; Maňáková E
    Cas Lek Cesk; 2012; 151(12):579-81. PubMed ID: 23387816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the mystery of thalidomide teratogenicity.
    Ito T; Handa H
    Congenit Anom (Kyoto); 2012 Mar; 52(1):1-7. PubMed ID: 22348778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide-induced limb defects: resolving a 50-year-old puzzle.
    Vargesson N
    Bioessays; 2009 Dec; 31(12):1327-36. PubMed ID: 19921660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CPS49-induced neurotoxicity does not cause limb patterning anomalies in developing chicken embryos.
    Mahony C; McMenemy S; Rafipay AJ; Beedie SL; Fraga LR; Gütschow M; Figg WD; Erskine L; Vargesson N
    J Anat; 2018 Apr; 232(4):568-574. PubMed ID: 29023763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The return of thalidomide: are birth defects surveillance systems ready?
    Yang Q; Khoury MJ; James LM; Olney RS; Paulozzi LJ; Erickson JD
    Am J Med Genet; 1997 Dec; 73(3):251-8. PubMed ID: 9415679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal limb deficiencies and the sclerotomes. An analysis of 378 dysmelic malformations induced by thalidomide.
    McCredie J; Willert HG
    J Bone Joint Surg Br; 1999 Jan; 81(1):9-23. PubMed ID: 10067994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New cases of thalidomide embryopathy in Brazil.
    Schuler-Faccini L; Soares RC; de Sousa AC; Maximino C; Luna E; Schwartz IV; Waldman C; Castilla EE
    Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):671-2. PubMed ID: 17676592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoepidemiology and thalidomide embryopathy surveillance in Brazil.
    Sales Luiz Vianna F; de Oliveira MZ; Sanseverino MT; Morelo EF; de Lyra Rabello Neto D; Lopez-Camelo J; Camey SA; Schuler-Faccini L
    Reprod Toxicol; 2015 Jun; 53():63-7. PubMed ID: 25828060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.
    Miller MT; Strömland K
    Teratology; 1999 Nov; 60(5):306-21. PubMed ID: 10525208
    [No Abstract]   [Full Text] [Related]  

  • 17. Facial palsy in individuals with thalidomide embryopathy: frequency and characteristics.
    Sjögreen L; Kiliaridis S
    J Laryngol Otol; 2012 Sep; 126(9):902-6. PubMed ID: 22892220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of thalidomide teratogenicity.
    Guenzler V
    Nat Med; 1999 Aug; 5(8):853. PubMed ID: 10426292
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesonephros has a role in limb development and is related to thalidomide embryopathy.
    Smith DM; Torres RD; Stephens TD
    Teratology; 1996 Sep; 54(3):126-34. PubMed ID: 8987155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thalidomide (Contergan) induced limb deficiency in Hungary?].
    Gidai J; Bács E; Czeizel E
    Orv Hetil; 2009 Jun; 150(25):1179-81. PubMed ID: 19497840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.